Back to Search Start Over

ISMICS Consensus Conference and Statements of Randomized Controlled Trials of Off-Pump versus Conventional Coronary Artery Bypass Surgery

Authors :
Bobby Yanagawa
Andre Lamy
Johannes Bonatti
Francis D. Ferdinand
Davy Cheng
Anno Diegeler
Marc Ruel
Michael J. Mack
Joseph F. Sabik
Nirav C. Patel
Stefano Benussi
Janet Martin
Teresa M. Kieser
Vipin Zamvar
John D. Puskas
Source :
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 10:219-229
Publication Year :
2015
Publisher :
SAGE Publications, 2015.

Abstract

ObjectiveAt this consensus conference, we developed evidence-informed consensus statements and recommendations on the practice of off-pump coronary artery bypass graft (OPCAB) by systematically reviewing and performing meta-analysis of the randomized controlled trials (RCTs) comparing OPCAB and conventional coronary artery bypass (CCAB).MethodsAll RCTs of OPCAB versus CCAB through April 2013 were screened, and 102 relevant RCTs (19,101 patients) were included in a systematic review and meta-analysis (15 RCTs of 9551 high-risk patients; and 87 RCTs of 9550 low-risk patients) in accordance with the Cochrane Collaboration and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. Consensus statements for the risks and benefits of OPCAB surgery in mortality, morbidity, and resource use were developed based on best available evidence.ResultsCompared to CCAB, it is reasonable to perform OPCAB to reduce risks of stroke [class IIa, level of evidence (LOE) A], renal dysfunction/failure (class IIa, LOE A), blood transfusion (class I, LOE A), respiratory failure (class I, LOE A), atrial fibrillation (class I, LOE A), wound infection (class I, LOE A), ventilation time, and ICU and hospital length of stay (class I, LOE A). However, OPCAB may be associated with a reduced number of grafts performed (class I, LOE A) and with diminished graft patency (class IIa, LOE A, with increased coronary reintervention at 1 year and beyond (class IIa, LOE A), as well as increased mortality at a median follow-up of 5 years (class IIb, LOE A).ConclusionsOPCAB compared with CCAB may improve outcomes in the short-term (stroke, renal dysfunction, blood transfusion, respiratory failure, atrial fibrillation, wound infection, ventilation time, and length of stay). However, over the longer-term, OPCAB may be associated with reduced graft patency, and increased risk of cardiac re-intervention and death.

Details

ISSN :
15590879 and 15569845
Volume :
10
Database :
OpenAIRE
Journal :
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Accession number :
edsair.doi.dedup.....2e72c72db3efc45f5d21199706a668ae
Full Text :
https://doi.org/10.1097/imi.0000000000000184